The Bavarian Cancer Research Center (BZKF) offers all patients and their relatives quick and uncomplicated access to scientifically sound information and the latest treatment options.
Early Clinical Trials:
The clinical units already in place at some BZKF sites for the implementation and investigation of the latest cancer treatments, so-called Early Clinical Trial Units (ECTU), will be further expanded at all six university sites throughout Bavaria in the near future. This will enable Bavaria-wide access to innovative diagnostic and therapeutic procedures, in particular participation in clinical trials, through the BZKF. Knowing the latest studies can be crucial for those affected: cancer patients whose treatment is carried out in the context of clinical trials are given special intensive care. In addition, they will have early access to innovative therapies that are not available elsewhere. Interested parties can search the study registers of the six BZKF sites for currently running studies on their tumor disease. Clinical studies provide new insights into the diagnosis and treatment of oncological diseases. Supportive therapies, e.g. the treatment of side effects, the use of integrative methods or the psycho-oncological care of cancer patients, can also be optimized thanks to clinical studies.